Skip to Content


National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Arthritis and Musculoskeletal and Skin Diseases Special Emphasis Panel. Review of Research Scientist Development—Research & Training (K01), Clinical Investigator—CIA (K08), Mentored Patient—Oriented Research Career Development (K23), Mentored Quantitative Research Career Development (K25), Conference (R13).

Date: March 15, 2005.

Time: 1 p.m. to 4 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Building 38, 8600 Rockville Pike, Bethesda, MD 20892, (Telephone Conference Call).

Contact Person: Eric H. Brown, BS, AB, MS, Scientific Review Administrator, National Institute of Arthritis, Musculoskeletal, and Skin Diseases, National Institutes of Health, 6701 Democracy Blvd., Room 824, MSC 4872, Bethesda, MD 20892-4874, (301) 435-0815,

Start Signature

(Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Musculoskeletal and Skin diseases Research, National Institutes of Health, HHS)

Dated: February 16, 2005.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy.

End Signature End Preamble

[FR Doc. 05-3563 Filed 2-23-05; 8:45 am]